AAO 2024: Elevating patient care through progress in minimally invasive glaucoma surgery

Commentary
Video

Vikas Chopra, MD, focused on minimally invasive glaucoma surgery (MIGS) and its significance in enhancing glaucoma treatment. He highlighted how MIGS allows ophthalmologists to perform interventions at an earlier stage and with increased safety, resulting in improved patient outcomes.

At the 2024 American Academy of Ophthalmology meeting, held from October 18 to 21 in Chicago, Illinois, US, Vikas Chopra, MD, from Doheny Eye Institute, UCLA, led a course on minimally invasive glaucoma surgery (MIGS), highlighting its transformative impact on ophthalmology and glaucoma management, especially in challenging cases. The course featured both lectures and a hands-on wet lab, allowing participants to engage directly with experts, review their techniques, and practice the steps in a supportive environment. Chopra highlighted the importance of teaching practical skills, as many attendees were seeking refreshers on procedures they had previously encountered in their own practices.

The evolution of technology in ophthalmology has played a crucial role in improving patient outcomes. Collaborations between ophthalmologists and industry partners help refine surgical techniques and develop safer devices, enhancing predictability and effectiveness in these interventions. Chopra stressed the significance of sharing “pearls,” or insider tips learned from experience, as these insights are often not documented in textbooks but are essential for successful surgery. This hands-on course brought together specialists who have performed hundreds of cases to share their expert knowledge and experience with attendees in the lab.

Chopra emphasized that patient safety is always a priority, and surgeons must understand their limitations. This mindset encourages humility and collaboration, as even experienced surgeons like himself consult with colleagues for advice on complex cases. He mentioned seeking input from ophthalmologist-peers, illustrating a shared commitment to the best patient outcomes.

The course reflects a broader trend in ophthalmology where practical knowledge, mentorship, and continuous learning are key to success. While technology advances, MIGS empowers physicians to address glaucoma earlier and more safely. By learning from specialists with extensive experience, attendees gain valuable insights, helping to foster a community that prioritizes excellence in patient care and precision in glaucoma treatment.

Recent Videos
3 experts are featured in this series.
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
Brent Kramer, MD, of Vance Thompson Vision speaks at the 2024 AAO meeting
AAO 2024: Bonnie An Henderson, MD, talks about advancing medical education with AI, robotics, and diverse learning methods
© 2024 MJH Life Sciences

All rights reserved.